DDrare: Database of Drug Development for Rare Diseases

Cdx-1135 (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
222	Primary nephrotic syndrome	1
223	Primary membranoproliferative glomerulonephritis	1

222. Primary nephrotic syndrome [ 234 clinical trials, 241 drugs, (DrugBank: 78 drugs), 59 drug target genes, 185 drug target pathways]

Searched query = "Primary nephrotic syndrome", "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01791686 (ClinicalTrials.gov)	January 2013	29/1/2013	Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	Dense Deposit Disease;Membranoproliferative Glomerulonephritis Type II;C3 Glomerulonephritis	Drug: CDX-1135	Celldex Therapeutics	NULL	Terminated	4 Years	N/A	Both	1	Phase 1	United States

223. Primary membranoproliferative glomerulonephritis [ 18 clinical trials, 14 drugs, (DrugBank: 7 drugs), 7 drug target genes, 14 drug target pathways]

Searched query = "Primary membranoproliferative glomerulonephritis", "Dense deposit disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 18 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01791686 (ClinicalTrials.gov)	January 2013	29/1/2013	Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	Dense Deposit Disease;Membranoproliferative Glomerulonephritis Type II;C3 Glomerulonephritis	Drug: CDX-1135	Celldex Therapeutics	NULL	Terminated	4 Years	N/A	Both	1	Phase 1	United States